Clinical Cancer Research  Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanaya, T.
Right arrow Articles by Inoue, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanaya, T.
Right arrow Articles by Inoue, M.
Clinical Cancer Research Vol. 6, 1239-1247, April 2000
© 2000 American Association for Cancer Research


Advances in Brief

Adenoviral Expression of p53 Represses Telomerase Activity through Down-Regulation of Human Telomerase Reverse Transcriptase Transcription

Taro Kanaya, Satoru Kyo1, Katsuyuki Hamada, Masahiro Takakura, Yasuhide Kitagawa, Hironobu Harada and Masaki Inoue

Departments of Obstetrics and Gynecology [T. K., S. K., M. T., M. I.] and Urology [Y. K.], School of Medicine, Kanazawa University, Ishikawa 920, Japan, and Departments of Obstetrics and Gynecology [K. H.] and Neurosurgery [H. H.], School of Medicine, Ehime University, Ehime 791-0204, Japan

Telomerase activation is a critical step in cellular immortality and oncogenesis. The activity of telomerase is known to be correlated with cell proliferation, but its regulation by cell cycle regulators is not well understood. In the present study, we examined the effects of p53 on telomerase activity. Wild-type p53 was introduced into SiHa cells via a recombinant adenoviral vector, Ad5CMV-p53, and change in telomerase activity was examined by quantitative telomerase assay. Telomerase activity in the Ad5CMV-p53-infected cells was significantly repressed 36 h after infection following down-regulation of human telomerase catalytic subunit [human telomerase reverse transcriptase (hTERT)] mRNA expression, whereas no change in telomerase activity was observed in the cells infected with control vector Ad5CMV-ß-gal. Interestingly, repression of telomerase activity was an early event that preceded cell growth inhibition or apoptosis induced by p53 overexpression, suggesting that p53 directly regulates telomerase activity. Transient expression assays using hTERT-promoter reporter constructs revealed that overexpression of p53 significantly repressed promoter activity of hTERT. 5'-Truncation of the promoter sequences revealed that the proximal core promoter region containing multiple binding sites for transcription factor Sp1 was responsible for p53-mediated transcriptional repression. Mutations in these binding sites for Sp1 led to failure of p53 to repress transcription. These findings suggest that p53 repressed telomerase activity through down-regulation of hTERT transcription and that interaction of p53 with Sp1 or other transcription factors may be involved in this regulation.




This article has been cited by other articles:


Home page
Cancer Res.Home page
K. Kumamoto, E. A. Spillare, K. Fujita, I. Horikawa, T. Yamashita, E. Appella, M. Nagashima, S. Takenoshita, J. Yokota, and C. C. Harris
Nutlin-3a Activates p53 to Both Down-regulate Inhibitor of Growth 2 and Up-regulate mir-34a, mir-34b, and mir-34c Expression, and Induce Senescence
Cancer Res., May 1, 2008; 68(9): 3193 - 3203.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. Zaky, C. Busso, T. Izumi, R. Chattopadhyay, A. Bassiouny, S. Mitra, and K. K. Bhakat
Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage
Nucleic Acids Res., March 1, 2008; 36(5): 1555 - 1566.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Astanehe, D. Arenillas, W. W. Wasserman, P. C. K. Leung, S. E. Dunn, B. R. Davies, G. B. Mills, and N. Auersperg
Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer
J. Cell Sci., March 1, 2008; 121(5): 664 - 674.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Renaud, E. M. Pugacheva, M. D. Delgado, R. Braunschweig, Z. Abdullaev, D. Loukinov, J. Benhattar, and V. Lobanenkov
Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors
Nucleic Acids Res., December 18, 2007; 35(21): 7372 - 7388.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. L. Nguyen, R. M. Kraft, M. Aubert, E. Goodwin, D. DiMaio, and J. A. Blaho
p53 and hTERT Determine Sensitivity to Viral Apoptosis
J. Virol., December 1, 2007; 81(23): 12985 - 12995.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Matsumoto, A. Takahashi, and T. Ohnishi
Nitric Oxide Radicals Choreograph a Radioadaptive Response
Cancer Res., September 15, 2007; 67(18): 8574 - 8579.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Racek, N. Mise, Z. Li, A. Stoll, and B. M. Putzer
C-terminal p73 Isoforms Repress Transcriptional Activity of the Human Telomerase Reverse Transcriptase (hTERT) Promoter
J. Biol. Chem., December 9, 2005; 280(49): 40402 - 40405.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Quante, S. Heeg, A. von Werder, G. Goessel, C. Fulda, M. Doebele, H. Nakagawa, R. Beijersbergen, H. E. Blum, and O. G. Opitz
Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis
Carcinogenesis, November 1, 2005; 26(11): 1879 - 1889.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. H. Toh, S. Kyo, and K. Sabapathy
Relief of p53-mediated Telomerase Suppression by p73
J. Biol. Chem., April 29, 2005; 280(17): 17329 - 17338.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. Goeman, D. Thormeyer, M. Abad, M. Serrano, O. Schmidt, I. Palmero, and A. Baniahmad
Growth Inhibition by the Tumor Suppressor p33ING1 in Immortalized and Primary Cells: Involvement of Two Silencing Domains and Effect of Ras
Mol. Cell. Biol., January 1, 2005; 25(1): 422 - 431.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Shats, M. Milyavsky, X. Tang, P. Stambolsky, N. Erez, R. Brosh, I. Kogan, I. Braunstein, M. Tzukerman, D. Ginsberg, et al.
p53-dependent Down-regulation of Telomerase Is Mediated by p21waf1
J. Biol. Chem., December 3, 2004; 279(49): 50976 - 50985.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
L. Gewin, H. Myers, T. Kiyono, and D. A. Galloway
Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex
Genes & Dev., September 15, 2004; 18(18): 2269 - 2282.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Takahashi, F. Higashino, M. Aoyagi, K. Yoshida, M. Itoh, S. Kyo, T. Ohno, T. Taira, H. Ariga, K. Nakajima, et al.
EWS/ETS Fusions Activate Telomerase in Ewing's Tumors
Cancer Res., December 1, 2003; 63(23): 8338 - 8344.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Muredda, K.-I. Nunoya, R. A. Burtch-Wright, E. U. Kurz, S. P. C. Cole, and R. G. Deeley
Cloning and Characterization of the Murine and Rat mrp1 Promoter Regions
Mol. Pharmacol., November 1, 2003; 64(5): 1259 - 1269.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. J. Peterson, O. Bogler, and S. M. Taylor
p53-Mediated Repression of DNA Methyltransferase 1 Expression by Specific DNA Binding
Cancer Res., October 15, 2003; 63(20): 6579 - 6582.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Kraemer, S. Fuessel, U. Schmidt, M. Kotzsch, B. Schwenzer, M. P. Wirth, and A. Meye
Antisense-mediated hTERT Inhibition Specifically Reduces the Growth of Human Bladder Cancer Cells
Clin. Cancer Res., September 1, 2003; 9(10): 3794 - 3800.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Takeda, H. Inaba, M. Yamazaki, S. Kyo, T. Miyamoto, S. Suzuki, T. Ehara, T. Kakizawa, M. Hara, L. J. DeGroot, et al.
Tumor-Specific Gene Therapy for Undifferentiated Thyroid Carcinoma Utilizing the Telomerase Reverse Transcriptase Promoter
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3531 - 3538.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
I. Horikawa and J. C. Barrett
Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms
Carcinogenesis, July 1, 2003; 24(7): 1167 - 1176.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Wirth, L. Zender, B. Schulte, B. Mundt, R. Plentz, K. L. Rudolph, M. Manns, S. Kubicka, and F. Kuhnel
A Telomerase-dependent Conditionally Replicating Adenovirus for Selective Treatment of Cancer
Cancer Res., June 15, 2003; 63(12): 3181 - 3188.
[Abstract] [Full Text] [PDF]


Home page
Sci Aging Knowl EnvironHome page
E. K. Heist, F. Huq, and R. Hajjar
Telomerase and the Aging Heart
Sci. Aging Knowl. Environ., May 14, 2003; 2003(19): pe11 - 11.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
H. Ryu, J. Lee, K. Zaman, J. Kubilis, R. J. Ferrante, B. D. Ross, R. Neve, and R. R. Ratan
Sp1 and Sp3 Are Oxidative Stress-Inducible, Antideath Transcription Factors in Cortical Neurons
J. Neurosci., May 1, 2003; 23(9): 3597 - 3606.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. A. DeFilippis, E. C. Goodwin, L. Wu, and D. DiMaio
Endogenous Human Papillomavirus E6 and E7 Proteins Differentially Regulate Proliferation, Senescence, and Apoptosis in HeLa Cervical Carcinoma Cells
J. Virol., December 20, 2002; 77(2): 1551 - 1563.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
S. A. Stewart
Multiple Levels of Telomerase Regulation
Mol. Interv., December 1, 2002; 2(8): 481 - 483.
[Abstract] [Full Text]


Home page
Microbiol. Mol. Biol. Rev.Home page
Y.-S. Cong, W. E. Wright, and J. W. Shay
Human Telomerase and Its Regulation
Microbiol. Mol. Biol. Rev., September 1, 2002; 66(3): 407 - 425.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E.-J. Kim, J.-S. Park, and S.-J. Um
Identification and Characterization of HIPK2 Interacting with p73 and Modulating Functions of the p53 Family in Vivo
J. Biol. Chem., August 23, 2002; 277(35): 32020 - 32028.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
L. J. Mauro and D. N. Foster
Regulators of Telomerase Activity
Am. J. Respir. Cell Mol. Biol., May 1, 2002; 26(5): 521 - 524.
[Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J.-L. Mergny, J.-F. Riou, P. Mailliet, M.-P. Teulade-Fichou, and E. Gilson
Natural and pharmacological regulation of telomerase
Nucleic Acids Res., February 15, 2002; 30(4): 839 - 865.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. S. Srivenugopal, J. Shou, S. R. S. Mullapudi, F. F. Lang Jr., J. S. Rao, and F. Ali-Osman
Enforced Expression of Wild-Type p53 Curtails the Transcription of the O6-Methylguanine-DNA Methyltransferase Gene in Human Tumor Cells and Enhances Their Sensitivity to Alkylating Agents
Clin. Cancer Res., May 1, 2001; 7(5): 1398 - 1409.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
Z. Wang, S. Kyo, M. Takakura, M. Tanaka, N. Yatabe, Y. Maida, M. Fujiwara, J. Hayakawa, M. Ohmichi, K. Koike, et al.
Progesterone Regulates Human Telomerase Reverse Transcriptase Gene Expression via Activation of Mitogen-activated Protein Kinase Signaling Pathway
Cancer Res., October 1, 2000; 60(19): 5376 - 5381.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. A. Johnson, T. A. Ince, and K. W. Scotto
Transcriptional Repression by p53 through Direct Binding to a Novel DNA Element
J. Biol. Chem., July 13, 2001; 276(29): 27716 - 27720.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Li and M. Y. W. Lee
Transcriptional Regulation of the Human DNA Polymerase delta Catalytic Subunit Gene POLD1 by p53 Tumor Suppressor and Sp1
J. Biol. Chem., August 3, 2001; 276(32): 29729 - 29739.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. S. Knight, M. A. Cotter II, and E. S. Robertson
The Latency-associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus Transactivates the Telomerase Reverse Transcriptase Promoter
J. Biol. Chem., June 15, 2001; 276(25): 22971 - 22978.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.